SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-23-074215
Filing Date
2023-06-23
Accepted
2023-06-23 17:03:54
Documents
79

Document Format Files

Seq Description Document Type Size
1 S-1 tm237052-9_s1.htm S-1 3568829
2 EXHIBIT 3.1 tm237052d7_ex3-1.htm EX-3.1 180870
3 EXHIBIT 3.3 tm237052d7_ex3-3.htm EX-3.3 165584
4 EXHIBIT 4.1 tm237052d7_ex4-1.htm EX-4.1 5647
5 EXHIBIT 4.2 tm237052d7_ex4-2.htm EX-4.2 5640
6 EXHIBIT 10.1 tm237052d7_ex10-1.htm EX-10.1 119897
7 EXHIBIT 10.2 tm237052d7_ex10-2.htm EX-10.2 103352
8 EXHIBIT 10.3 tm237052d7_ex10-3.htm EX-10.3 182016
9 EXHIBIT 10.4 tm237052d7_ex10-4.htm EX-10.4 276757
10 EXHIBIT 10.5 tm237052d7_ex10-5.htm EX-10.5 117544
11 EXHIBIT 10.6 tm237052d7_ex10-6.htm EX-10.6 103119
12 EXHIBIT 10.7 tm237052d7_ex10-7.htm EX-10.7 44527
13 EXHIBIT 10.8 tm237052d7_ex10-8.htm EX-10.8 27585
14 EXHIBIT 10.9 tm237052d7_ex10-9.htm EX-10.9 46304
15 EXHIBIT 10.10 tm237052d7_ex10-10.htm EX-10.10 21160
16 EXHIBIT 10.11 tm237052d7_ex10-11.htm EX-10.11 103848
17 EXHIBIT 10.12 tm237052d7_ex10-12.htm EX-10.12 101341
18 EXHIBIT 10.13 tm237052d7_ex10-13.htm EX-10.13 65212
19 EXHIBIT 10.14 tm237052d7_ex10-14.htm EX-10.14 31192
20 EXHIBIT 10.15 tm237052d7_ex10-15.htm EX-10.15 72787
21 EXHIBIT 10.16 tm237052d7_ex10-16.htm EX-10.16 9686
22 EXHIBIT 10.17 tm237052d7_ex10-17.htm EX-10.17 62688
23 EXHIBIT 10.18 tm237052d7_ex10-18.htm EX-10.18 40012
24 EXHIBIT 10.19 tm237052d7_ex10-19.htm EX-10.19 42117
25 EXHIBIT10.20 tm237052d7_ex10-20.htm EX-10.20 87112
26 EXHIBIT 10.21 tm237052d7_ex10-21.htm EX-10.21 17213
27 EXHIBIT 10.22 tm237052d7_ex10-22.htm EX-10.22 291103
28 EXHIBIT 10.23 tm237052d7_ex10-23.htm EX-10.23 16591
29 EXHIBIT 10.24 tm237052d7_ex10-24.htm EX-10.24 401949
30 EXHIBIT 10.25 tm237052d7_ex10-25.htm EX-10.25 56478
31 EXHIBIT 10.26 tm237052d7_ex10-26.htm EX-10.26 257981
32 EXHIBIT 10.27 tm237052d7_ex10-27.htm EX-10.27 48470
33 EXHIBIT 23.1 tm237052d7_ex23-1.htm EX-23.1 1810
34 EX-FILING FEES tm237052d7_ex-filingfees.htm EX-FILING FEES 27130
35 GRAPHIC lg_sagimet-4c.jpg GRAPHIC 40042
36 GRAPHIC bc_weekdosing-4c.jpg GRAPHIC 88246
37 GRAPHIC bc_pipeline01-4c.jpg GRAPHIC 150781
38 GRAPHIC fc_overview-4c.jpg GRAPHIC 97317
39 GRAPHIC fc_patients-4c.jpg GRAPHIC 148180
40 GRAPHIC fc_excessliver-4c.jpg GRAPHIC 83370
41 GRAPHIC fc_denifanstat-4c.jpg GRAPHIC 83698
42 GRAPHIC fc_pathogenesis-4c.jpg GRAPHIC 177297
43 GRAPHIC fc_clinicaltrial4c.jpg GRAPHIC 66855
44 GRAPHIC bc_liverfatbio-4c.jpg GRAPHIC 96998
45 GRAPHIC bc_inflammation-4c.jpg GRAPHIC 85489
46 GRAPHIC bc_fibrosiss-4c.jpg GRAPHIC 55214
47 GRAPHIC fc_metabolic-4c.jpg GRAPHIC 58576
48 GRAPHIC fc_clinicaltrial-4c.jpg GRAPHIC 73450
49 GRAPHIC bc_biomarkerimaging-4c.jpg GRAPHIC 75573
50 GRAPHIC ph_denifanstat-4c.jpg GRAPHIC 174205
51 GRAPHIC bc_lipotoxicity-4c.jpg GRAPHIC 115107
52 GRAPHIC bc_fibrosisbio-4c.jpg GRAPHIC 53177
53 GRAPHIC bc_lipidbio-4c.jpg GRAPHIC 56927
54 GRAPHIC tb_treatment-4c.jpg GRAPHIC 142382
55 GRAPHIC bc_denifanstat-4c.jpg GRAPHIC 31490
56 GRAPHIC tb_fibrogenic-4c.jpg GRAPHIC 67467
57 GRAPHIC bc_collagen-4c.jpg GRAPHIC 126647
58 GRAPHIC fc_precision-4c.jpg GRAPHIC 116752
59 GRAPHIC bc_tripalmitin-4c.jpg GRAPHIC 26859
60 GRAPHIC lc_predictive-4c.jpg GRAPHIC 53447
61 GRAPHIC fc_diseaserationale-4c.jpg GRAPHIC 142821
62 GRAPHIC tb_oncology-4c.jpg GRAPHIC 127756
63 GRAPHIC bc_solidtumors-4c.jpg GRAPHIC 88587
64 GRAPHIC tm237052d7_ex10-16img020.jpg GRAPHIC 977
65 GRAPHIC tm237052d7_ex10-16img029.jpg GRAPHIC 1208
66 GRAPHIC tm237052d7_ex10-16img015.jpg GRAPHIC 19491
67 GRAPHIC tm237052d7_ex10-16img018.jpg GRAPHIC 977
68 GRAPHIC tm237052d7_ex10-16img021.jpg GRAPHIC 977
69 GRAPHIC tm237052d7_ex10-16img022.jpg GRAPHIC 977
70 GRAPHIC tm237052d7_ex10-16img023.jpg GRAPHIC 977
71 GRAPHIC tm237052d7_ex10-16img024.jpg GRAPHIC 977
72 GRAPHIC tm237052d7_ex10-16img025.jpg GRAPHIC 977
73 GRAPHIC tm237052d7_ex10-16img026.jpg GRAPHIC 977
74 GRAPHIC tm237052d7_ex10-16img027.jpg GRAPHIC 977
75 GRAPHIC tm237052d7_ex10-16img028.jpg GRAPHIC 977
76 GRAPHIC tm237052d7_ex4-1img001.jpg GRAPHIC 250117
77 GRAPHIC tm237052d7_ex4-1img002.jpg GRAPHIC 119409
78 GRAPHIC tm237052d7_ex4-2img001.jpg GRAPHIC 291681
79 GRAPHIC tm237052d7_ex4-2img002.jpg GRAPHIC 119409
  Complete submission text file 0001104659-23-074215.txt   11448962
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-272901 | Film No.: 231038574
SIC: 2834 Pharmaceutical Preparations